NIH-funded research Fellowship grant

Exploring how a protein called folliculin affects fat secretion in liver disease.

Official title: Investigating folliculin as a regulator of VLDL-TG secretion in non-alcoholic fatty liver disease and steatohepatitis

Funded at University of Pennsylvania · NIH-11015848 · Data updated 2026-11-12

This study is looking at how a protein called folliculin affects fat release from the liver in people with non-alcoholic fatty liver disease (NAFLD) and its more serious form, non-alcoholic steatohepatitis (NASH), to find new ways to help improve liver health.

More Fatty Liver research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startMarch 1, 2023
Project endFebruary 28, 2026
Funding year2025
Award (this year)$39,796
NIH project number5F31DK135277-03
Project IDNIH-11015848 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with non-alcoholic fatty liver disease or non-alcoholic steatohepatitis.

Less likely to help

Patients with liver disease due to alcohol consumption or other non-metabolic causes may not benefit from this research.

What this research studies

This research investigates the role of a protein known as folliculin in the regulation of fat secretion from the liver, particularly in patients with non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH). The study aims to understand how folliculin influences various lipid processes in the liver, which could lead to new therapeutic strategies. By examining the effects of folliculin on fat metabolism in laboratory models, researchers hope to identify potential targets for treatment that could improve liver health and reduce disease progression.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for patients suffering from NAFLD and NASH, potentially preventing severe liver complications.

How similar studies have gone: Previous research has shown promise in targeting lipid metabolism for treating liver diseases, making this approach a potentially valuable avenue for further exploration.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Thorsheim, Chelsea — University of Pennsylvania
  • Study coordinator: Thorsheim, Chelsea

Related research

Other NIH-funded projects on the same topics.

  • Role of fat droplets in liver fat and inflammatory signals in NAFLD

    A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11623263

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

  • How the TET1 gene affects non-alcoholic fatty liver disease

    Researchers are looking at whether changes in the TET1 gene and DNA 'tagging' (methylation) play a role in adult non-alcoholic fatty liver disease.

    NIH research State University New York Stony Brook · Stony Brook, United States · NIH-11447065

  • Hepatocellular Genetic Clues for Fatty Liver in Hispanic Adults

    A large NIH grant helps researchers study why fatty liver develops in Hispanic adults and how genetics interact with lifestyle to affect risk.

    NIH research University of Texas Rio Grande Valley · Edinburg, United States · NIH-11421441

  • Toxic fats, vitamin B12 loss, and AHR may drive fatty liver disease

    This grant looks at how certain environmental chemicals may trigger liver damage linked to fatty liver disease and how a vitamin found in the blood could be affected.

    NIH research Michigan State University · East Lansing, United States · NIH-11398883

  • Glutamine and T cells in fatty liver disease

    A study explores how liver glutamine levels affect inflammatory CD4+ T cells in fatty liver disease to find potential new ways to reduce liver inflammation.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11388863

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.